A. Mizutani

发表

Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.

Yuta Tanaka, B. Saito, Kazunobu Aoyama, 2018, Bioorganic & medicinal chemistry.

LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B.

S. Iwasaki, T. Nomura, Kazuhide Nakamura, 2017, Cancer research.

Anti‐angiogenic and anti‐tumor effects of TAK‐593, a potent and selective inhibitor of vascular endothelial growth factor and platelet‐derived growth factor receptor tyrosine kinase

O. Kitahara, Naoki Miyamoto, S. Imamura, 2013, Cancer science.

Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication

K. Toyoshima, H. Miyashita, A. Hayashi, 2017, Oncogenesis.

Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication

K. Toyoshima, H. Miyashita, A. Hayashi, 2017, Oncogenesis.

A novel pyrrolo[3, 2‐d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet‐derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis

Yuya Oguro, S. Imamura, A. Hori, 2012, Cancer science.

Antitumor activity of a novel and orally available inhibitor of serine palmitoyltransferase.

R. Adachi, Atsushi Kiba, M. Hirayama, 2017, Biochemical and biophysical research communications.

CTX-712, a Novel Clk Inhibitor Targeting Myeloid Neoplasms with SRSF2 Mutation

S. Ogawa, H. Makishima, Y. Nannya, 2019, Blood.

A Novel Inhibitor of c-Met and VEGF Receptor Tyrosine Kinases with a Broad Spectrum of In Vivo Antitumor Activities

Naoki Miyamoto, S. Imamura, Kazuhide Nakamura, 2013, Molecular Cancer Therapeutics.

MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody

J. Lawson, P. Vincent, K. Okada, 2017, Molecular Cancer Therapeutics.